Maravai LifeSciences Holdings, Inc. (MRVI) Free cash flow 2019–2025
Maravai LifeSciences Holdings, Inc. (MRVI) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$70.7MFY2025 · since FY2019: $7.0M → -$70.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$70.7M | -218.7% |
| FY2024 | -$22.2M | -136.6% |
| FY2023 | $60.7M | -88.3% |
| FY2022 | $518.9M | +46.7% |
| FY2021 | $353.7M | +179.0% |
| FY2020 | $126.8M | +1719.7% |
| FY2019 | $7.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More MRVI financial trends
MRVI RevenueMRVI Net incomeMRVI Net marginMRVI Gross profitMRVI Gross marginMRVI Operating incomeMRVI Operating marginMRVI Operating cash flowMRVI Capital expendituresMRVI Return on equityMRVI Stock buybacksMRVI Dividends paidMRVI Total assetsMRVI Total liabilitiesMRVI Shareholders’ equityMRVI overview →